Clinical Trial Update: An Observational Study of TNKase in Patients Enrolled in the National Registry of Myocardial Infarction 4 and 5 (POST)

View source ↗

Summary

An observational study of TNKase (tenecteplase) in patients enrolled in the NRMI 4 and NRMI 5 registry has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• TNKASE (tenecteplase)

Snippet

Sponsor: Genentech, Inc. | Conditions: Acute Myocardial Infarction | Status: COMPLETED